006280.KO Green Cross Corp

Healthcare Biotechnology Korea Stock Exchange
142,300 KRW
Close of Nov 5, 2026
105,900 181,974
Market cap
KRW 1.62T
P/E
-
P/B
1.28x
ROE
3.6%
Dividend yield
1.16%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 006280.KO undervalued?

Graham number

The Graham number of Green Cross Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Green Cross Corp fundamental analysis

No fundamental analysis for Green Cross Corp yet.

Green Cross Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Green Cross Corp

GC Biopharma Corp., a biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea, India, Taiwan, Japan, China, Malaysia, and internationally. It provides over-the-counter drugs, such as Acustop Cataplasma for Analgesic and anti-inflammatory effect; Kenhancer plaster for anti-inflammatory; and Zenol Cool Type and Zenol Mild Hot Type drugs to treat anti-inflammatory and pain relief. The company also offers Albumin-GCC injection (inj.) for hypoalbuminemia…

Full company profile